Defects in the availability of haem substrates or the catalytic activity of the terminal enzyme in haem biosynthesis, ferrochelatase (Fech), impair haem synthesis and thus cause human congenital anaemias 1, 2 . The interdependent functions of regulators of mitochondrial homeostasis and enzymes responsible for haem synthesis are largely unknown. To investigate this we used zebrafish genetic screens and cloned mitochondrial ATPase inhibitory factor 1 (atpif1) from a zebrafish mutant with profound anaemia, pinotage (pnt tq209 ). Here we describe a direct mechanism establishing that Atpif1 regulates the catalytic efficiency of vertebrate Fech to synthesize haem. The loss of Atpif1 impairs haemoglobin synthesis in zebrafish, mouse and human haematopoietic models as a consequence of diminished Fech activity and elevated mitochondrial pH. To understand the relationship between mitochondrial pH, redox potential, [2Fe-2S] clusters and Fech activity, we used genetic complementation studies of Fech constructs with or without [2Fe-2S] clusters in pnt, as well as pharmacological agents modulating mitochondrial pH and redox potential. The presence of [2Fe-2S] cluster renders vertebrate Fech vulnerable to perturbations in Atpif1-regulated mitochondrial pH and redox potential. Therefore, Atpif1 deficiency reduces the efficiency of vertebrate Fech to synthesize haem, resulting in anaemia. The identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development. An ATPIF1 deficiency may contribute to important human diseases, such as congenital sideroblastic anaemias and mitochondriopathies.
A deficiency in haem, which is used in a wide variety of metabolic and regulatory pathways in cells 3 , results in pathological conditions that range from mild anaemia to early in utero death 4 . As an essential component of haemoglobin, the individual enzymes and substrates of haem biosynthesis have been well studied 2 ; however, key gaps remain in our knowledge of genes that regulate intracellular iron and haem transport and homeostasis. This incomplete understanding prevents researchers from developing targeted therapies for a broad range of disorders, including congenital anaemias and porphyrias, as well as metabolic and neurological disorders.
We recovered pnt, a zebrafish (Danio rerio) non-lethal recessive mutant, from an unbiased ethyl nitrosourea (ENU) mutagenesis screen 5 for defects in circulating erythroid cells 6 . pnt embryos were anaemic (Fig. 1a ) despite normal expression of the erythroid cell markers b-globin and band-3 (data not shown). On the basis of red cell indices, the erythrocytes from pnt embryos that survive to adult stage exhibited hypochromic, microcytic anaemia ( Supplementary Fig. 1a ). Histological analysis of adult pnt haematopoietic tissues showed no gross morphological defects ( Supplementary Fig. 1b ).
To identify a candidate gene for the pnt locus we carried out positional cloning and chromosomal walk, which identified the most probable candidate gene to be mitochondrial ATPase inhibitory factor 1 (zgc:162207; which we refer to hereafter as atpif1a) ( Fig. 1b ). Phylogenetic analysis showed that an ATPase inhibitory factor 1-like protein (zgc: 153321; which we refer to hereafter as atpif1b) on chromosome 17 is 71% similar to atpif1a at the amino acid level (Fig. 1c) , and is probably the result of gene duplication in teleosts 7 . Peptide alignments further displayed human (ATPIF1, chromosome 1) and mouse (Atpif1, chromosome 4) orthologues for atpif1a and atpif1b ( Fig. 1c ). Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) showed reduced levels of atpif1a messenger RNA in pnt embryos ( Fig. 1d ) and pnt adult kidney marrow compared to their respective wild-type controls ( Supplementary Fig. 1c ). The levels of atpif1b mRNA were, however, unchanged in pnt embryos ( Fig. 1d ) and elevated two to threefold in pnt adult kidney marrow ( Supplementary  Fig. 1c ). Thus, atpif1a is probably the gene disrupted in the pnt locus.
Previous studies have shown that mitochondrial Atpif1 regulates the proton motive force via mitochondrial influx of H 1 ions, mitochondrial structure, and ATP synthesis, indicating that Atpif1 is required in a wide range of metabolically active tissues 8 . The broad requirement for Atpif1 is reinforced by the ubiquitous expression of both atpif1a and atpif1b in zebrafish embryos ( Supplementary Fig. 1d ) and Atpif1 in various mouse adult and fetal organs ( Supplementary Fig. 1e ).
To verify the loss-of-function phenotype for atpif1a, we injected two atpif1a antisense splice-blocking ( Fig. 2a ) and translational-blocking morpholinos (data not shown) to knock down atpif1a expression in zebrafish embryos. The atpif1a-silenced embryos (morphants) lacked haemoglobinized cells, as detected by o-dianisidine staining, thereby phenocopying the anaemia in pnt embryos ( Fig. 2a ). The anaemic phenotype in the morphant embryos correlates with a reduction of atpif1a mRNA levels, verifying that the splice-blocking morpholinos accurately targeted atpif1a ( Fig. 2b , Supplementary Discussion 1 and Supplementary Fig. 2a-d ).
To validate further that atpif1a is the gene disrupted in pnt, we overexpressed atpif1a sense-strand complementary RNA (cRNA) in pnt embryos and subsequently evaluated their haemoglobinization. To assess the specificity of our complementation assay, we also injected pnt embryos with non-functional atpif1a cRNA harbouring a missense mutation (E26A) in the regulatory inhibitory domain 9 . Only functional atpif1a complemented the anaemia in pnt embryos ( Fig. 2c ), thereby confirming that atpif1a is the gene disrupted in pnt embryos. Consistent with a two-to threefold increase in atpif1b expression in surviving pnt adults ( Supplementary Fig. 1c ), the ectopic expression of atpif1b cRNA also complemented pnt anaemia ( Fig. 2c ), a result of their redundant function. These data indicate that the hypomorphic and viable phenotype of pnt could be attributed to the ability of atpif1b to partially compensate for the loss of function of atpif1a (Supplementary Fig. 1c ). This is in contrast to other situations with paralogues, such as the mitoferrin (mfrn) transporters 10 , which do not partially compensate for loss of their other paralogue.
To identify the genetic mutation in the pnt locus, we first sequenced the open reading frame and splice junctions of the atpif1a gene and did not find a mutation. Instead, we discovered an AC insertional mutation in the 39 untranslated region (39 UTR) of the atpif1a gene ( Fig. 2d ). This mutation was linked to the pnt locus following the distinct segregation of wild-type and mutant conformations on single-strand conformational polymorphism (SSCP) analysis ( Fig. 2e ). To establish the functional consequences of the 39 UTR mutation on the stability of atpif1a mRNA, we designed constructs containing the zebrafish atpif1a open reading frame fused with either the wild-type or mutant 39 UTR sequences, and transfected mouse erythroleukaemia (MEL) cells with each construct individually for stable selection ( Supplementary Fig. 2e ). A decrease in steady-state atpif1a mRNA levels in cells harbouring mutant 39 UTR constructs as compared to the wild-type construct was shown by qRT-PCR analysis ( Fig. 2f and Supplementary Discussion 2). These data demonstrate that the mutation in the 39 UTR of the atpif1a gene destabilizes its steady-state mRNA. The observed decrease in the atpif1a mRNA level in pnt embryos ( Fig. 1d ) is consistent with the ascribed function for the 39 UTR mutation, which destabilizes atpif1a steady-state mRNA and leads to its degradation 11 .
In mammalian cells, Atpif1 is located in the inner mitochondrial membrane and primarily regulates the function of the F 1 F 0 -ATP synthase 12 . There is, however, no direct evidence suggesting a role for Atpif1 in haem synthesis or erythropoiesis. To ascertain the role of Atpif1 in mammalian haem synthesis, we used short hairpin RNAs (shRNAs) to stably silence Atpif1 in differentiating mammalian haematopoietic cells: human primary CD34 1 (hCD34 1 ) cells, mouse primary fetal liver (MPFL) cells and MEL cells. The reduced number of haemoglobinized cells in Atpif1-silenced hCD34 1 and MEL cells ( Fig. 3a and Supplementary Fig. 3a ) and the reduced haemoglobin content in MPFL cells transduced with Atpif1 shRNAs ( Supplementary Fig. 3b , c) demonstrate a conserved haem-specific function of Atpif1. Consistent with a high turnover of haem in developing erythroblasts 13 , we observed that the haemoglobinization defect was specific to Atpif1-silenced differentiating erythroid cells. Similarly, we observed that during terminal erythroid maturation the expression of Atpif1 protein increases along with other proteins required for haem synthesis 14 , such as Fech and mitoferrin1 (Mfrn1, also called Slc25a37) ( Supplementary Fig. 3d ) Analogous Atpif1-silencing experiments performed in non-erythroid 
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(NIH 3T3) and undifferentiated MEL cells showed no measurable haem defects ( Supplementary Fig. 4 ). This indicates that Atpif1 is essential for terminal erythroid maturation and is not critical for haem synthesis in non-erythroid cells and early erythroid progenitors. Under physiological conditions, the F 1 F 0 -ATP synthase generates ATP by consuming the proton motive force existing across the inner mitochondrial membrane, transporting H 1 ions from the intermembrane space into the mitochondrial matrix 8, 15 . When respiration is inhibited or the mitochondrial membrane potential (DYm) is decreased, the F 1 F 0 -ATP synthase reverses the direction of H 1 transport, dissipating ATP in the attempt to maintain the proton motive force 8, 15 . Under these conditions, Atpif1 inhibits the reversal of the F 1 F 0 -ATP synthase to decrease ATP hydrolysis, thereby counteracting the maintenance of the mitochondrial membrane potential (DYm) and proton motive force 8 . To determine the causal association between the roles of Atpif1 in mitochondrial homeostasis and mammalian haem synthesis, we used stable Atpif1-shRNA-silenced MEL cells. Consistent with the silencing of Atpif1, the Atpif1 protein levels were reduced (Fig. 3b) . To test the possibility of global mitochondrial structural dysfunction we examined several integral mitochondrial proteins, such as the b-subunit of ATP synthase, complex IV, voltage-dependent anionic-selective channel protein 1, and heat shock protein 60 (Fig. 3b) , and their protein expression was found to be normal. In addition, electron microscopy and biochemical analysis revealed normal mitochondrial integrity, indicating that the gross structural architecture of mitochondria in Atpif1-silenced MEL cells was preserved ( Fig. 3b and Supplementary  Fig. 5 ). However, we found that the knockdown of Atpif1 in differentiating MEL cells caused a depletion of cellular ATP levels (Supplementary Figs 6a, b) , an increase in mitochondrial membrane potential (DYm) ( Fig. 3c and Supplementary Fig. 6c ), and an alkalinization of the mitochondria ( Supplementary Fig. 6d ).
Haem synthesis requires the incorporation of ferrous ion (Fe 21 ) into protoporphyrin IX (PPIX), which is catalysed by Fech on the matrix side of the inner mitochondrial membrane 16 . Because the loss of Atpif1 primarily results in a haem synthesis defect in differentiating erythroid cells, we analysed the mitochondrial levels of haem, haem substrates and their related enzymes. We have previously shown that Mfrn1, an inner mitochondrial membrane transporter, facilitates the import of iron into erythroid mitochondria 10 , which is dependent upon the mitochondrial DYm 17,18 . Consistent with the increased mitochondrial DYm in Atpif1-silenced MEL cells ( Fig. 3c and Supplementary Fig. 6c ), the uptake of radioisotope-labelled iron ( 59 Fe) into the mitochondria was increased (Fig. 3d) , indicating that the loss of Atpif1 increases mitochondrial iron load. Iron transported into the mitochondrial matrix is either used to make iron and sulphur [2Fe-2S] clusters or incorporated into PPIX by Fech to generate haem [1] [2] [3] 13 . Atpif1-silenced MEL cells had normal levels of mitochondrial PPIX (Fig. 3e ), suggesting that the enzymes and substrates necessary to make this haem precursor are not rate-limiting. The incorporation of 59 Fe into PPIX to generate haem, however, was reduced ( Fig. 3f ), despite sufficient levels of Fech substrates, iron and PPIX. We predicted that the catalytic efficiency of Fech was compromised, therefore we measured the activity and protein expression levels of Fech. Although normal levels of Fech protein were present, Fech activity was reduced ( Fig. 4a ), suggesting that the defect in haem synthesis in pnt could be attributed to a reduction in Fech activity. We found that the basal mitochondrial pH of control cells was pH 7.4, and for Atpif1-silenced MEL cells it was pH 8.6 (Fig. 4b , Supplementary Discussion 3 and Supplementary Fig. 6d ). Because Atpif1silenced MEL cells have higher basal mitochondrial pH, we predicted that elevated mitochondrial pH might influence Fech's efficiency in making haem, and secondly that the Fech isolated from these cells would be already detrimentally affected by the elevated pH. To test our hypothesis, we preincubated the purified human FECH at pH 7.4, pH 8.0, pH 8.5 and pH 9.0 for 1 h, and then ran the FECH assay at pH 7.4. We found that preincubation at elevated pH decreased human FECH activity and thus reduced its capacity to make haem ( Supplementary  Fig. 6e ). In addition, we found that increasing the mitochondrial pH to pH 8.5 or pH 9.0 would further lower Fech activity in both control and Atpif1-silenced MEL cells (Fig. 4c) , indicating that Fech activity is a function of mitochondrial pH ( Supplementary Discussion 3) . Together, these data indicate that the ability of Fech to generate haem was compromised due to the increase in mitochondrial pH that occurs in Atpif1-silenced differentiating MEL cells.
We further found that lowering mitochondrial membrane potential and thus mitochondrial pH-using pharmacological agents carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) at 1 mM concentration for 1 hr or 2,4-dinitro-phenol (2,4-DNP) at 500 mM for 1 h 19 -could rescue the anaemic phenotype in Atpif1-silenced MEL cells (Fig. 4d) . These data reinforce our observation that Atpif1 regulates haem synthesis by means of its modulation of the mitochondrial membrane potential (DYm) and mitochondrial pH. Fig. 7a ) and mitochondrial aconitase (Fig. 4e) , show normal activity. The post-translational stability of Fech apoprotein depends on iron availability and an intact [2Fe-2S] cluster assembly machinery 20, 21 . 
Atpif1-silenced MEL cells have normal cytosolic and mitochondrial [2Fe-2S] cluster biogenesis because proteins dependent on [2Fe-2S] cluster synthesis, such as cytosolic xanthine oxidase (Supplementary
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However, the functional role of the [2Fe-2S] cluster in Fech activity remains unknown ( Supplementary Discussion 4) . All vertebrate Fech enzymes possess [2Fe-2S] clusters, whereas Fech from the yeast Saccharomyces cerevisiae does not have a cluster 16, 21 . On the basis of these data and our current observations, we proposed that the [2Fe-2S] cluster of Fech could influence Fech activity in situ by rendering Fech responsive to changes in the mitochondrial proton motive force, and thus mitochondrial pH and redox potential.
To test experimentally whether [2Fe-2S]-cluster-containing Fech responded to the capacity of Atpif1 to regulate mitochondrial proton motive force and thus mitochondrial pH, we designed Fech constructs containing or lacking [2Fe-2S] (zebrafish and yeast Fech, respectively) and also containing a vertebrate mitochondrial targeting propeptide. Both constructs, irrespective of the presence of [2Fe-2S] clusters, functionally complemented a genetic deficiency for zebrafish Fech in freixenet 6, 22 (frx tu271 , Supplementary Fig. 7b ). When either the zebrafish or yeast Fech cRNA was injected into pnt embryos, the yeast Fech rescued pnt anaemia, whereas zebrafish Fech did not (Fig. 4f) . These data suggest that it is the [2Fe-2S] cluster of the zebrafish Fech that makes this enzyme vulnerable to pH perturbations of the mitochondrial matrix in atpif1-deficient pnt embryos. Therefore, Atpif1 has an essential role in stabilizing the activity of [2Fe-2S]-cluster-containing Fech by modulating changes in mitochondrial matrix pH. On the basis of our results, we infer that yeast Fech, lacking the [2Fe-2S] cluster, is resistant to mitochondrial pH changes in pnt embryos. Consistent with our observation that the activity of yeast Fech would be unaffected by mitochondrial pH (Fig. 4f) , we found that the yeast inh1 knockout did not produce a defect in haem synthesis (data not shown). These data show that Atpif1 regulates haem synthesis in higher vertebrate erythroid tissues, whereas its counterpart in S. cerevisiae, Inh1, does not regulate haem synthesis.
The redox potential of mitochondrial matrix at pH 7.4 is 2280 mV and it is reduced to 2370 mV at pH 8.4 23 . As the mitochondrial pH is inversely related to mitochondrial redox potential 23 , we further analysed the susceptibility of the [2Fe-2S] of Fech to reduction in mitochondrial redox potential. When we treated human FECH (with [2Fe-2S]) and yeast Fech (without [2Fe-2S]) with a strong reducing agent, sodium dithionate (DTN, 10 mM), we found that the DTN treatment could only reduce the activity of human and not yeast Fech (Fig. 4g ). This further suggests that [2Fe-2S] of vertebrate Fech is sensitive to the reduction in the redox potential. Thus, Fech activity is reduced in Atpif1-silenced MEL cells as its [2Fe-2S] cluster is sensitive to an elevation of mitochondrial pH ( Fig. 4b-d , f) and a reduction in redox potential (Fig. 4g) , and not because of a defect in [2Fe-2S] cluster biosynthetic assembly ( Fig. 4e and Supplementary Fig. 7a ).
To exclude an anaemic phenotype in pnt as a causal effect of reactive oxygen species (ROS)-induced haem degradation, we treated pnt mutant embryos with N-acetylcysteine (NAC, 10 mM for 48 h), a potent antioxidant used for ROS studies in zebrafish embryos 24, 25 , and found that NAC could not rescue pnt anaemia (Fig. 4h ). This demonstrates that the anaemic phenotype in pnt is not due to increased ROS generation. The haem oxygenase 1 enzyme (Hmox1) is a ROS-responsive, cellular enzyme responsible for haem degradation 26 We found normal transcript levels of Hmox1 in control and Atpif1-silenced MEL cells ( Supplementary Fig. 7c ). Consistent with our model, it has been demonstrated that only overexpression of Atpif1 gene, not loss of Atpif1 activity, induces ROS production, independent of the Hif1a pathway 27 , and that the overexpression of Atpif1 did not affect cellular hydrogen peroxide levels, indicating that the Atpif1-mediated superoxide signal is of mild intensity and localized in mitochondria 27 . Together, these data suggest that ROS and haem degradation are not responsible for the haem defect we observed in Atpif1-deficient erythroid cells. unless n values are otherwise stated, for all data n refers to three independent biological replicates; bars without an asterisk are not statistically significant; all samples were analysed for statistical significance.
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Atpif1 modulates the mitochondrial pH and redox potential and thus allows Fech to efficiently catalyse the incorporation of iron into PPIX to produce haem. Loss of Atpif1 allows the mitochondrial pH-and consequently the redox potential-to change to a level that reduces [2Fe-2S] cluster-containing Fech activity, thereby reducing haem synthesis, resulting in hypochromic anaemia in pnt (Fig. 4i) . Previous human studies have identified ALAS2, FXN, ABCB7 and SLC25A38 as the genetic causes of congenital sideroblastic anaemias 28, 29 . Data presented herein demonstrate that Atpif1 should now be added to the list of proteins whose native function is required for normal erythropoiesis. This makes ATPIF1 a candidate gene for the understanding and treatment of human sideroblastic anaemias and mitochondrial disorders.
METHODS SUMMARY
All procedures were approved by the Animal Care and Use Committee of Boston Children's Hospital. We performed complete blood count and Wright-Geimsa analyses on peripheral blood recovered from adult pnt mutants. Genetic mapping and positional cloning were used to identify zgc:162207 (atpif1a) as the candidate gene for the pnt locus on zebrafish chromosome 19. We used qRT-PCR using TaqMan gene expression assays (Applied Biosystems) to measure levels of atpif1a and atpif1b mRNA. Morpholinos (Gene Tools) against splice sites of atpif1a and atpif1b were designed and injected into wild-type embryos to verify a loss-offunction phenotype. The cRNA for atpif1a, atpif1a (E26A), and atpif1b were injected into pnt embryos for complementation tests. The cDNA prepared from wild-type and pnt embryos was sequenced and the mutation in the 39 UTR of the atpif1a sequence was verified using SSCP gels.
We silenced Atpif1 in hCD34 1 , MPFL and MEL cells using shRNAs. The Atpif1-silenced, differentiated hCD34 1 and MEL cells were stained with o-dianisidine to measure haemoglobinized cells, whereas MPFL cells were treated with Drabkin's reagent to measure relative haemoglobin content. The loss of Atpif1 protein and the state of mitochondrial structural proteins in MEL cells were verified using western blotting and electron microscopic analyses. We analysed the fluorescent intensities of tetramethylrhodamine ethyl ester (TMRE) as a function of mitochondrial membrane potential, magnesium green as a function of ATP levels, and the ratio of carboxy SNARF-1 to Mitotracker green as a function of the mitochondrial matrix pH 8, 12 .
We prepared 59 Fe-saturated transferrin and measured 59 Fe incorporated in mitochondria and complexed in haem using a gamma counter. We examined PPIX levels and the catalytic efficiency of Fech in MEL cells using spectrophotometric analysis. The MEL cells were treated with FCCP and 2,4-DNP, followed by analysis for haemoglobinized cells. Human and yeast Fech were treated with DTN and their catalytic efficiency was subsequently measured. Aconitase activity was determined as a measure of [2Fe-2S] cluster levels 30 . The cRNA for zebrafish Fech or yeast Fech was injected into pnt embryos, and their efficiency in rescuing the anaemia in pnt was measured using o-dianisidine staining and verified by using SSCP analysis 10 . Statistical analyses were performed by paired or un-paired Student's t-tests. Significance was set at P , 0.05.
